Skip to content

Does the TOOKIE Vest Reduce Line Fall Out Rate in Children?

A Prospective Study to Assess Whether the Tookie Vest for Oncology Reduces Central Line Fall Out Rate in the Paediatric Oncology Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04324970
Enrollment
40
Registered
2020-03-27
Start date
2019-01-15
Completion date
2020-09-06
Last updated
2020-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer

Brief summary

The objective of the trial is to assess whether the TOOKIE vest is an effective intervention in reducing line fall out. All oncology patients with a tunneled central line will be approached to participate in this study. Following informed consent they will be issued with a TOOKIE vest.

Detailed description

All oncology patients with a tunneled central line will be approached to participate in this study. Following informed consent they will be issued with a TOOKIE vest. Lines will be studied for the duration they are in situ. This will vary depending on the underlying diagnosis and treatment regime. One hundred central line insertions for oncology patients will be prospectively identified and be given the TOOKIE Vest to wear. Data will be collated for each group regarding age, gender, diagnosis, type of central access inserted, duration of line, reason for removal, in cases of infection the infected organism will be documented, date of each fall out.

Interventions

DEVICETookie Vest

Tookie Vest

Sponsors

Manchester University NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Any child receiving treatment for malignancy at Royal Manchester Children's Hospital * Patients with a tunnelled central line inserted for treatment of their malignancy

Exclusion criteria

• Any child having a portacath inserted as their mode of central access

Design outcomes

Primary

MeasureTime frame
Central line fall out rateapproximately 1 year

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026